AZD1979
98%
- Product Code: 99670
CAS:
1254035-84-1
| Molecular Weight: | 462.5 g./mol | Molecular Formula: | C₂₅H₂₆N₄O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
AZD1979 is primarily used in the field of oncology research, where it is investigated for its potential as a therapeutic agent targeting specific cancer pathways. It functions as an inhibitor of certain kinases that play a role in tumor growth and progression. Researchers are exploring its efficacy in preclinical studies to determine its ability to inhibit cancer cell proliferation and survival. The compound is of particular interest in the development of targeted therapies for cancers that are driven by dysregulated kinase activity. Its application is focused on understanding its pharmacokinetics, pharmacodynamics, and safety profile to assess its suitability for clinical trials. AZD1979 represents a promising candidate in the ongoing search for more effective and selective cancer treatments.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £5,265.24 |
+
-
|
| 0.005 | 10-20 days | £13,135.95 |
+
-
|
AZD1979
AZD1979 is primarily used in the field of oncology research, where it is investigated for its potential as a therapeutic agent targeting specific cancer pathways. It functions as an inhibitor of certain kinases that play a role in tumor growth and progression. Researchers are exploring its efficacy in preclinical studies to determine its ability to inhibit cancer cell proliferation and survival. The compound is of particular interest in the development of targeted therapies for cancers that are driven by dysregulated kinase activity. Its application is focused on understanding its pharmacokinetics, pharmacodynamics, and safety profile to assess its suitability for clinical trials. AZD1979 represents a promising candidate in the ongoing search for more effective and selective cancer treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :